Printer Friendly

Onyx Pharmaceuticals to Present at Lehman Global Healthcare Conference.

EMERYVILLE, Calif., March 15 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at the Lehman Global Healthcare conference on Tuesday, March 20, at 3:15 p.m. Eastern Time. Interested parties may access a live webcast of the presentation at:

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through April 20, 2007.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative therapies that target the molecular mechanisms that cause cancer. The company is developing Nexavar(R), a small molecule drug, with Bayer Pharmaceuticals Corporation. Nexavar has been approved for the treatment of advanced kidney cancer. For more information about Onyx's pipeline and activities, visit the company's web site at:

NOTE: Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.

CONTACT: Alexandra Santos, +1-510-597-6504, for Onyx Pharmaceuticals

Web site:
COPYRIGHT 2007 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 15, 2007
Previous Article:PR Newswire Entertainment Summary, Thursday, March 15, 2007.
Next Article:Bookham Tunable Laser Assembly Selected to Support 40Gb/s DWDM Systems.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters